BMS - Lance Armstrong
And finally, the world’s most decorated and then undecorated cyclist Lance Armstrong who survived testicular cancer in 1997 and went on to win number of cycling awards including seven Tours de France, as well as receiving a host of accolades over the following 15 years.
Bristol-Myers Squibb (BMS) said Armstrong was treated with three of its cancer drugs in his battle against the disease and partnered with him in a number of sporting events. In 2005, BMS launched a 3,300-mile ‘Tour of Hope’ to raise awareness about cancer clinical trials.
“At Bristol-Myers Squibb, we know just how tough an enemy cancer is - particularly when so many people still feel there is little hope in preventing or treating the disease,” Peter Dolan, CEO in 2005 said at the time. “That's why we have teamed up with cancer survivor and champion cyclist Lance Armstrong for the Bristol-Myers Squibb Tour of Hope.”
In 2013, Armstrong was stripped of his titles after confessing to using illegal performance enhancing drugs through his career, including EPO, Human Growth Hormone, testosterone and blood doping.